Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report

BACKGROUND: The management of unresectable or metastatic gastrointestinal stromal tumors (GISTs) has previously been difficult as they are resistant to conventional chemotherapy and radiation. The development of imatinib mesylate has made a major impact on the management of advanced GISTs. It is app...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Brett, Yip, Desmond, Goldstein, David, Waring, Paul, Beshay, Victoria, Chong, Guan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC524360/
https://www.ncbi.nlm.nih.gov/pubmed/15473910
http://dx.doi.org/10.1186/1471-2407-4-74

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC524360/
https://www.ncbi.nlm.nih.gov/pubmed/15473910
http://dx.doi.org/10.1186/1471-2407-4-74

Ejemplares similares